Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y. Feng, Johann S. de Bono, Mark A. Rubin, et al.
Molecular Cell (2015) Vol. 58, Iss. 6, pp. 925-934
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

NAD + in aging, metabolism, and neurodegeneration
Eric Verdin
Science (2015) Vol. 350, Iss. 6265, pp. 1208-1213
Closed Access | Times Cited: 1037
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser, Veronica Y. Sabelnykova, Takafumi N. Yamaguchi, et al.
Nature (2017) Vol. 541, Iss. 7637, pp. 359-364
Closed Access | Times Cited: 557
PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
A.G. Thorsell, T. Ekblad, T. Karlberg, et al.
Journal of Medicinal Chemistry (2016) Vol. 60, Iss. 4, pp. 1262-1271
Open Access | Times Cited: 330
Serine ADP-Ribosylation Depends on HPF1
Juán José Bonfiglio, Pietro Fontana, Qi Zhang, et al.
Molecular Cell (2017) Vol. 65, Iss. 5, pp. 932-940.e6
Open Access | Times Cited: 315
The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA repair (2018) Vol. 71, pp. 177-182
Open Access | Times Cited: 299
PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
Ting Hong, Guang Lei, Xue Chen, et al.
Redox Biology (2021) Vol. 42, pp. 101928-101928
Open Access | Times Cited: 248
Readers of poly(ADP-ribose): designed to be fit for purpose
Federico Teloni, Matthias Altmeyer
Nucleic Acids Research (2015) Vol. 44, Iss. 3, pp. 993-1006
Open Access | Times Cited: 226
Serine is a new target residue for endogenous ADP-ribosylation on histones
Orsolya Leidecker, Juán José Bonfiglio, Thomas Colby, et al.
Nature Chemical Biology (2016) Vol. 12, Iss. 12, pp. 998-1000
Open Access | Times Cited: 220
Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Medicine (2016) Vol. 22, Iss. 2, pp. 194-201
Open Access | Times Cited: 217
Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype
Nicolas Malaquin, Aurélie Martinez, Françis Rodier
Experimental Gerontology (2016) Vol. 82, pp. 39-49
Closed Access | Times Cited: 212
PARP-1 and its associated nucleases in DNA damage response
Yijie Wang, Weibo Luo, Yingfei Wang
DNA repair (2019) Vol. 81, pp. 102651-102651
Open Access | Times Cited: 209
Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition
Lu Yang, Youyou Zhang, Weiwei Shan, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 400
Open Access | Times Cited: 206
Macrodomains: Structure, Function, Evolution, and Catalytic Activities
J.G.M. Rack, Dragutin Perina, Ivan Ahel
Annual Review of Biochemistry (2016) Vol. 85, Iss. 1, pp. 431-454
Open Access | Times Cited: 204
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9
Chunsong Yang, Kasey Jividen, Adam Spencer, et al.
Molecular Cell (2017) Vol. 66, Iss. 4, pp. 503-516.e5
Open Access | Times Cited: 191
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics
Abhishek Chandra, Jyotika Rajawat
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3553-3553
Open Access | Times Cited: 161
Exosomes in skin photoaging: biological functions and therapeutic opportunity
Amirhossein Hajialiasgary Najafabadi, Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30
PARPs and ADP-Ribosylation: 50 Years … and Counting
W. Lee Kraus
Molecular Cell (2015) Vol. 58, Iss. 6, pp. 902-910
Open Access | Times Cited: 166
Moonlighting at replication forks – a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51
Arun Mouli Kolinjivadi, Vincenzo Sannino, Anna De Antoni, et al.
FEBS Letters (2017) Vol. 591, Iss. 8, pp. 1083-1100
Open Access | Times Cited: 149
NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival
Michael M. Murata, Xiangduo Kong, Emmanuel Moncada, et al.
Molecular Biology of the Cell (2019) Vol. 30, Iss. 20, pp. 2584-2597
Open Access | Times Cited: 142
The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
Tatiana Kamaletdinova, Zahra Fanaei‐Kahrani, Zhao‐Qi Wang
Cells (2019) Vol. 8, Iss. 12, pp. 1625-1625
Open Access | Times Cited: 133
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Francesco Ciccarese, Elisabetta Zulato, Stefano Indraccolo
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 125
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma
Valeria Colicchia, Marialaura Petroni, Giulia Guarguaglini, et al.
Oncogene (2017) Vol. 36, Iss. 33, pp. 4682-4691
Closed Access | Times Cited: 92
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P. Lieberman, et al.
Cancer Research (2016) Vol. 76, Iss. 15, pp. 4516-4524
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top